Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-09

Clinical Trial Update: Feasibility Study: Enzymatic Debridement in Patients With Partial Thickness Burns [Phase 2]

View source ↗

Summary

Phase 2 feasibility study evaluating enzymatic debridement for partial thickness burns has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: MediWound Ltd | Conditions: Burn | Phase 2 | Status: COMPLETED